Rabie Hossein Mohammad, Esfandiari Hamed, Rikhtegar Mohammad Hassan, Hekmat Vahid
Ophthalmology Department, Ophthalmic Research Center, Torfe Medical Center, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Pasdaran Ave. Boostan 9 St., Tehran, 1666694516, Iran.
Ophthalmic Research Center, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Int Ophthalmol. 2018 Feb;38(1):145-150. doi: 10.1007/s10792-016-0435-9. Epub 2017 Jan 4.
To describe our experience with exchanging sulcus-fixated single-piece intraocular lens (IOL) with 3-piece IOLs for management of pigmentary glaucoma.
In this retrospective study, records of patients who underwent sulcus-fixated single-piece IOL exchanged with 3-piece IOLs were retrieved, and demographic and baseline data of patients, type of IOL, pre- and post-IOL exchange BCVA, IOP, number of anti-glaucoma medications, and optic nerve head examination were documented. Baseline and final examinations were analyzed and compared.
Mean age of the patients was 59 ± 10 years, and 5 (41.6%) were female. Mean interval between primary cataract extraction operation and IOL exchange was 17 ± 5 months. Nine patients received in sulcus implantation of Alcon SA60AT, and three patients had SN60WF model at the end of primary surgery. BCVA changed insignificantly from 0.06 ± 0.06 logMAR to 0.06 ± 0.06 after IOL exchange. (P = 0.22) IOP was controlled in 8 cases (66.6%), but four cases (33.3%) needed glaucoma surgery to further control glaucoma condition. IOP decreased significantly from preoperative 17 ± 3 to 14 ± 1 mmHg postoperatively. Patients with advanced age and higher baseline IOP were more likely to undergo glaucoma surgery after IOL exchange. (P = 0.07 and 0.00, respectively).
single-piece IOL exchange with 3-piece IOL dramatically decreases pigment release and reduces IOP. Those with advanced age and higher IOP are less likely to respond to IOL exchange and may need glaucoma surgery to control high intraocular pressure.
描述我们用三件式人工晶状体替换沟固定单片式人工晶状体治疗色素性青光眼的经验。
在这项回顾性研究中,检索了接受沟固定单片式人工晶状体替换为三件式人工晶状体的患者记录,并记录了患者的人口统计学和基线数据、人工晶状体类型、人工晶状体置换前后的最佳矫正视力(BCVA)、眼压(IOP)、抗青光眼药物数量以及视神经乳头检查情况。对基线和最终检查进行分析和比较。
患者的平均年龄为59±10岁,5名(41.6%)为女性。初次白内障摘除手术与人工晶状体置换之间的平均间隔为17±5个月。9名患者在沟内植入了爱尔康SA60AT,3名患者在初次手术结束时使用的是SN60WF型号。人工晶状体置换后,BCVA从0.06±0.06 logMAR变化至0.06±0.06,变化不显著(P = 0.22)。8例(66.6%)眼压得到控制,但4例(33.3%)需要青光眼手术来进一步控制青光眼病情。眼压从术前的17±3显著降至术后的14±1 mmHg。年龄较大且基线眼压较高的患者在人工晶状体置换后更有可能接受青光眼手术(分别为P = 0.07和0.00)。
用三件式人工晶状体替换单片式人工晶状体可显著减少色素释放并降低眼压。年龄较大且眼压较高的患者对人工晶状体置换的反应较小,可能需要青光眼手术来控制高眼压。